Shiny Nair, PhD
Research ScientistCards
About
Research
Publications
2026
Spatially resolved mechanisms of liver carcinogenesis in Gaucher disease implicate lipid-driven immunosuppressive niches
Nair S, Mehta S, Ain N, Zhang X, Mistry P. Spatially resolved mechanisms of liver carcinogenesis in Gaucher disease implicate lipid-driven immunosuppressive niches. Molecular Genetics And Metabolism 2026, 147: 109558. DOI: 10.1016/j.ymgme.2025.109558.Peer-Reviewed Original ResearchGaucher disease therapy mitigates monoclonal gammopathy: Clinical outcomes and glucosylsphingosine trajectories
Ain N, Yang R, Klinger K, Nair S, Mistry P. Gaucher disease therapy mitigates monoclonal gammopathy: Clinical outcomes and glucosylsphingosine trajectories. Molecular Genetics And Metabolism 2026, 147: 109303. DOI: 10.1016/j.ymgme.2025.109303.Peer-Reviewed Original ResearchBeyond ERT/SRT: A neuro-pulmonary-lymphatic spatial-omics atlas redefines pathology and guides immunotherapy in neuronopathic Gaucher disease
Mistry P, Fattahi N, Mehta S, Nair S. Beyond ERT/SRT: A neuro-pulmonary-lymphatic spatial-omics atlas redefines pathology and guides immunotherapy in neuronopathic Gaucher disease. Molecular Genetics And Metabolism 2026, 147: 109552. DOI: 10.1016/j.ymgme.2025.109552.Peer-Reviewed Original Research
2025
Refining Mouse Models of Gaucher Disease: Advancing Mechanistic Insights, Biomarker Discovery, and Therapeutic Strategies
Fattahi N, Ruan J, Belinsky G, Xing S, Mistry P, Nair S. Refining Mouse Models of Gaucher Disease: Advancing Mechanistic Insights, Biomarker Discovery, and Therapeutic Strategies. International Journal Of Molecular Sciences 2025, 26: 11915. PMID: 41465340, PMCID: PMC12733336, DOI: 10.3390/ijms262411915.Peer-Reviewed Original ResearchMouse modelGaucher diseaseMouse model of Gaucher diseaseMouse model developmentContribution of macrophagesBiallelic pathogenic variantsLineage-specific modelsClinically meaningful endpointsGD mouse modelPatient-derived mutationsModel of Gaucher diseaseSubtypes of GDImmune dysregulationTherapeutic responseMulti-omics integrationB cellsPathogenic variantsTherapeutic strategiesPerinatal lethalityLysosomal disorderClinical translationImmune architectureBiomarker developmentGene editing platformMultisystem conditionPrecision genomic profiling in Gaucher disease: insights from atypical presentations
Saith A, Ain N, Ruan J, Kasaiyan M, Jain D, Israel G, Mehta S, Bamford N, Nair S, Mistry P. Precision genomic profiling in Gaucher disease: insights from atypical presentations. Frontiers In Genetics 2025, 16: 1553036. PMID: 41282474, PMCID: PMC12634035, DOI: 10.3389/fgene.2025.1553036.Peer-Reviewed Original ResearchWhole-exome sequencingEpigenetic modifiersAutosomal dominant polycystic kidney diseaseGenetic disordersGD patientsPathological accumulationGaucher diseaseSingle-gene disordersChronic metabolic inflammationGenome integrityComplex phenotypesAccumulation of glucosylceramidePrecision medicine strategiesHereditary cancer predispositionModel of precision medicineCohort of GD patientsCancer predispositionBiological pathwaysTertiary care centerDominant polycystic kidney diseaseFamilial Mediterranean feverIndividualized therapeutic approachPhenotypic heterogeneityGenetic diagnosisGenomic profilingModeling bone marrow microenvironment and hematopoietic dysregulation in Gaucher disease through VavCre mediated Gba deletion
Belinsky G, Ruan J, Fattahi N, Mehta S, Boddupalli C, Mistry P, Nair S. Modeling bone marrow microenvironment and hematopoietic dysregulation in Gaucher disease through VavCre mediated Gba deletion. Human Molecular Genetics 2025, 34: 952-966. PMID: 40197748, PMCID: PMC12085781, DOI: 10.1093/hmg/ddaf045.Peer-Reviewed Original ResearchGD miceImmune dysregulationGaucher diseaseExpansion of monocytesImmune cell deconvolutionKnockout modelsBone marrow microenvironmentGlucocerebrosidase activityC57BL/6 J backgroundDeficient glucocerebrosidase activityGaucher cell infiltrationInfluence disease severityGD biomarkersGD pathologyGD pathophysiologyLysosomal storage disorderImmune landscapeDendritic cellsHematopoietic stemMarrow microenvironmentAccumulation of glucosylceramideVav-CreBone marrowCell infiltrationHematopoietic cellsMolecular cell atlas of the brain in neuronopathic Gaucher disease
Nair S, Mehta S, Belinsky G, Mistry P. Molecular cell atlas of the brain in neuronopathic Gaucher disease. Molecular Genetics And Metabolism 2025, 144: 108868. DOI: 10.1016/j.ymgme.2024.108868.Peer-Reviewed Original ResearchInvestigating the genomic basis of phenotypic diversity among siblings in Gaucher disease
Ain N, Kulkarni N, Ruan J, Ruan A, Nair S, Mehta S, Mistry P. Investigating the genomic basis of phenotypic diversity among siblings in Gaucher disease. Molecular Genetics And Metabolism 2025, 144: 108633. DOI: 10.1016/j.ymgme.2024.108633.Peer-Reviewed Original ResearchApoe-Abca1 axis is involved in the pathogenesis of Gaucher disease
Xing S, Nair S, Mistry P. Apoe-Abca1 axis is involved in the pathogenesis of Gaucher disease. Molecular Genetics And Metabolism 2025, 144: 108987. DOI: 10.1016/j.ymgme.2024.108987.Peer-Reviewed Original Research
2024
VavCre mediated conditional deletion of Gba in mice recapitulates human Gaucher disease type 1, a platform to investigate the role of myeloid cells and altered hematopoiesis
Nair S, Belinsky G, Mistry P. VavCre mediated conditional deletion of Gba in mice recapitulates human Gaucher disease type 1, a platform to investigate the role of myeloid cells and altered hematopoiesis. Molecular Genetics And Metabolism 2024, 141: 107978. DOI: 10.1016/j.ymgme.2023.107978.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
News
News
Get In Touch
Contacts
Email
Mailing Address
Yale School of Medicine
Department of Medicine (Digestive Diseases), PO Box 208019
New Haven, CT 06520-8019
United States